Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review

Detalhes bibliográficos
Autor(a) principal: Oliveira, Alan Paulo Amaral
Data de Publicação: 2021
Outros Autores: Schafranek , Alícia Rocha de Mesquita, Carvalho , Larissa de Oliveira Briganti, Vitro , Mariana Martins de, Frazão , Renata Messias, Nascimento , Victor Alves, Oliveira, Pollyanna Francielli de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/13251
Resumo: The SARS-CoV-2 spread and the installation of a pandemic generated drastic changes in society's lifestyle, in health practices, and in the way we do and consume science. There are countless uncertainties regarding the virus and its health implications, especially for individuals from vulnerable groups, such as oncologic patients. The aim of this systematic review was to identify what has been the reality of oncology in the SARS-CoV-2 pandemic. A systematic review was carried out on the Pubmed® platform, based on the Prisma protocol, using the following keywords were searched: COVID-19 and Cancer. Among the 94 works selected, including systematic reviews, reviews, randomized trials, multicenter studies, meta-analysis, controlled clinical-trials, comparative studies and case reports, only 36 publications corresponded to the purpose of this study and were used. The results showed that, despite the large volume of studies, there is no consensus concerning gold standard measures. As individuals with cancer tend to evolve with more severe conditions when infected with SARS-CoV-2, oncology services have adopted protocols to guarantee adequate management and prevent the spread of the infection onto its facilities. The possible scarcity of resources during the SARS-CoV-2 pandemic brought the necessity to adapt adjust clinical conduct in oncology. Considering the severity and the possibility of a sudden progression of some types of cancer, the professionals must analyze all cases individually to determine the best approach.
id UNIFEI_cea883a58ae3f3aef61e9135a883b9fe
oai_identifier_str oai:ojs.pkp.sfu.ca:article/13251
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review Desafíos en el manejo del cáncer durante la pandemia de SARS-CoV-2: una revisión sistemática Desafios no tratamento do câncer durante a pandemia de SARS-CoV-2: uma revisão sistemáticaCOVID-19SARS-CoV-2CâncerOncologiaOncologia cirúrgica.COVID-19SARS-CoV-2CancerOncologySurgical oncology.COVID-19SARS-CoV-2CáncerOncologíaOncología quirúrgica.The SARS-CoV-2 spread and the installation of a pandemic generated drastic changes in society's lifestyle, in health practices, and in the way we do and consume science. There are countless uncertainties regarding the virus and its health implications, especially for individuals from vulnerable groups, such as oncologic patients. The aim of this systematic review was to identify what has been the reality of oncology in the SARS-CoV-2 pandemic. A systematic review was carried out on the Pubmed® platform, based on the Prisma protocol, using the following keywords were searched: COVID-19 and Cancer. Among the 94 works selected, including systematic reviews, reviews, randomized trials, multicenter studies, meta-analysis, controlled clinical-trials, comparative studies and case reports, only 36 publications corresponded to the purpose of this study and were used. The results showed that, despite the large volume of studies, there is no consensus concerning gold standard measures. As individuals with cancer tend to evolve with more severe conditions when infected with SARS-CoV-2, oncology services have adopted protocols to guarantee adequate management and prevent the spread of the infection onto its facilities. The possible scarcity of resources during the SARS-CoV-2 pandemic brought the necessity to adapt adjust clinical conduct in oncology. Considering the severity and the possibility of a sudden progression of some types of cancer, the professionals must analyze all cases individually to determine the best approach.La propagación del SARS-CoV-2 y la instalación de una pandemia generaron cambios drásticos en el estilo de vida de la sociedad, en las prácticas de salud y en la forma en que hacemos y consumimos ciencia. Existen innumerables incertidumbres sobre el virus y sus implicaciones para la salud, especialmente para las personas de grupos vulnerables, como los pacientes oncológicos. El objetivo de esta revisión sistemática fue identificar cuál ha sido la realidad de la oncología en la pandemia del SARS-CoV-2. Se realizó una revisión sistemática en la plataforma Pubmed®, basada en el protocolo Prisma, mediante la búsqueda de las siguientes palabras clave: COVID-19 y Cancer. De los 94 trabajos seleccionados, entre revisiones sistemáticas, revisiones, ensayos aleatorizados, estudios multicéntricos, metaanálisis, ensayos clínicos controlados, estudios comparativos e informes de casos, solo 36 publicaciones correspondieron al propósito de este estudio y fueron utilizadas. Los resultados mostraron que, a pesar del gran volumen de estudios, no existe un consenso sobre las medidas estándar de oro. Dado que las personas con cáncer tienden a evolucionar con condiciones más graves cuando se infectan con SARS-CoV-2, los servicios de oncología han adoptado protocolos para garantizar un manejo adecuado y prevenir la propagación de la infección a sus instalaciones. La posible escasez de recursos durante la pandemia de SARS-CoV-2 trajo la necesidad de adaptar la conducta clínica en oncología. Teniendo en cuenta la gravedad y la posibilidad de una progresión brusca de algunos tipos de cáncer, los profesionales deben analizar todos los casos de forma individual para determinar el mejor abordaje.A disseminação do SARS-CoV-2 e a instalação de uma pandemia geraram mudanças drásticas no estilo de vida da sociedade, nas práticas de saúde e na forma como fazemos e consumimos ciência. São inúmeras as incertezas em relação ao vírus e suas implicações para a saúde, principalmente para indivíduos de grupos vulneráveis, como os pacientes oncológicos. O objetivo desta revisão sistemática foi identificar qual tem sido a realidade da oncologia na pandemia do SARS-CoV-2. Foi realizada uma revisão sistemática na plataforma Pubmed®, com base no protocolo Prisma, utilizando os seguintes descritores: COVID-19 e Câncer. Entre os 94 trabalhos selecionados, incluindo revisões sistemáticas, revisões, ensaios randomizados, estudos multicêntricos, metanálises, ensaios clínicos controlados, estudos comparativos e relatos de caso, apenas 36 publicações corresponderam ao objetivo deste estudo e foram utilizadas. Os resultados mostraram que, apesar do grande volume de estudos, não há consenso sobre as medidas padrão-ouro. Como os indivíduos com câncer tendem a evoluir para quadros mais graves quando infectados pelo SARS-CoV-2, os serviços de oncologia têm adotado protocolos para garantir o manejo adequado e prevenir a disseminação da infecção em suas instalações. A possível escassez de recursos durante a pandemia do SARS-CoV-2 trouxe a necessidade de adequar a conduta clínica em oncologia. Considerando a gravidade e a possibilidade de progressão súbita de alguns tipos de câncer, os profissionais devem analisar todos os casos individualmente para determinar a melhor conduta.Research, Society and Development2021-03-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1325110.33448/rsd-v10i3.13251Research, Society and Development; Vol. 10 No. 3; e25910313251Research, Society and Development; Vol. 10 Núm. 3; e25910313251Research, Society and Development; v. 10 n. 3; e259103132512525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/13251/11963Copyright (c) 2021 Alan Paulo Amaral Oliveira; Alícia Rocha de Mesquita Schafranek ; Larissa de Oliveira Briganti Carvalho ; Mariana Martins de Vitro ; Renata Messias Frazão ; Victor Alves Nascimento ; Pollyanna Francielli de Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessOliveira, Alan Paulo Amaral Schafranek , Alícia Rocha de Mesquita Carvalho , Larissa de Oliveira Briganti Vitro , Mariana Martins de Frazão , Renata Messias Nascimento , Victor Alves Oliveira, Pollyanna Francielli de2021-03-28T12:03:35Zoai:ojs.pkp.sfu.ca:article/13251Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:34:38.694593Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
Desafíos en el manejo del cáncer durante la pandemia de SARS-CoV-2: una revisión sistemática
Desafios no tratamento do câncer durante a pandemia de SARS-CoV-2: uma revisão sistemática
title Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
spellingShingle Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
Oliveira, Alan Paulo Amaral
COVID-19
SARS-CoV-2
Câncer
Oncologia
Oncologia cirúrgica.
COVID-19
SARS-CoV-2
Cancer
Oncology
Surgical oncology.
COVID-19
SARS-CoV-2
Cáncer
Oncología
Oncología quirúrgica.
title_short Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
title_full Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
title_fullStr Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
title_full_unstemmed Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
title_sort Challenges in cancer management during SARS-CoV-2 pandemic: a systematic review
author Oliveira, Alan Paulo Amaral
author_facet Oliveira, Alan Paulo Amaral
Schafranek , Alícia Rocha de Mesquita
Carvalho , Larissa de Oliveira Briganti
Vitro , Mariana Martins de
Frazão , Renata Messias
Nascimento , Victor Alves
Oliveira, Pollyanna Francielli de
author_role author
author2 Schafranek , Alícia Rocha de Mesquita
Carvalho , Larissa de Oliveira Briganti
Vitro , Mariana Martins de
Frazão , Renata Messias
Nascimento , Victor Alves
Oliveira, Pollyanna Francielli de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Alan Paulo Amaral
Schafranek , Alícia Rocha de Mesquita
Carvalho , Larissa de Oliveira Briganti
Vitro , Mariana Martins de
Frazão , Renata Messias
Nascimento , Victor Alves
Oliveira, Pollyanna Francielli de
dc.subject.por.fl_str_mv COVID-19
SARS-CoV-2
Câncer
Oncologia
Oncologia cirúrgica.
COVID-19
SARS-CoV-2
Cancer
Oncology
Surgical oncology.
COVID-19
SARS-CoV-2
Cáncer
Oncología
Oncología quirúrgica.
topic COVID-19
SARS-CoV-2
Câncer
Oncologia
Oncologia cirúrgica.
COVID-19
SARS-CoV-2
Cancer
Oncology
Surgical oncology.
COVID-19
SARS-CoV-2
Cáncer
Oncología
Oncología quirúrgica.
description The SARS-CoV-2 spread and the installation of a pandemic generated drastic changes in society's lifestyle, in health practices, and in the way we do and consume science. There are countless uncertainties regarding the virus and its health implications, especially for individuals from vulnerable groups, such as oncologic patients. The aim of this systematic review was to identify what has been the reality of oncology in the SARS-CoV-2 pandemic. A systematic review was carried out on the Pubmed® platform, based on the Prisma protocol, using the following keywords were searched: COVID-19 and Cancer. Among the 94 works selected, including systematic reviews, reviews, randomized trials, multicenter studies, meta-analysis, controlled clinical-trials, comparative studies and case reports, only 36 publications corresponded to the purpose of this study and were used. The results showed that, despite the large volume of studies, there is no consensus concerning gold standard measures. As individuals with cancer tend to evolve with more severe conditions when infected with SARS-CoV-2, oncology services have adopted protocols to guarantee adequate management and prevent the spread of the infection onto its facilities. The possible scarcity of resources during the SARS-CoV-2 pandemic brought the necessity to adapt adjust clinical conduct in oncology. Considering the severity and the possibility of a sudden progression of some types of cancer, the professionals must analyze all cases individually to determine the best approach.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/13251
10.33448/rsd-v10i3.13251
url https://rsdjournal.org/index.php/rsd/article/view/13251
identifier_str_mv 10.33448/rsd-v10i3.13251
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/13251/11963
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 3; e25910313251
Research, Society and Development; Vol. 10 Núm. 3; e25910313251
Research, Society and Development; v. 10 n. 3; e25910313251
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052671865126912

Registros relacionados